A Case Report of a Carbamazepine Overdose With Focus on Pharmacokinetic Aspects

Abstract

In this article a case of carbamazepine overdose is reported. It is common to use immuno-based methods in the field of therapeutic drug monitoring but it might be difficult to adapt such values to toxicological cases. For carbamazepine overdoses it is recommended also to determine the metabolite carbamazepine-10,11-epoxide. Especially for critical conditions a definite substance identification should be performed. In addition, quantifying main metabolites is recommended for an acute clinical toxicological assessment.

Key words

therapeutic drug monitoring - toxicological assessment

• References

• 1 Ellenhorn MJ, Barceloux DG. Carbamazepine. In: Ellenhorn MJ, Barceloux DG. editors. Medical Toxicology: Diagnosis and Treatment of Human Poisoning. New York: Elsevier; 1988: 231-240
• 2 Baselt RC. Carbamazepine. In: Baselt RC. editor Disposition of Toxic Drugs and Chemicals in Man. Foster City, CA: Biomedical Publications; 2008: 225-228
• 3 Hundt HKL, Aucamp AK, Müller FO. Pharmacokinetic aspects of carbamazepine and its two major metabolites in plasma during overdosage. Human Toxicology 1983; 2: 607-614
• 4 Spiller HA, Abad D. Management of carbamazepine overdose. Pediatr Emerg Care 2001; 17: 452-456
• 5 Abbott AxSym System. Carbamazepine. Wiesbaden, Germany: Abbott; 2011
• 6 Patsalos PN, Krishna S, Elyas AA et al. Carbamazepine and carbamazepine-10,11-epoxide pharmacokinetics in an overdose patient. Human Toxicology 1987; 6: 241-244
• 7 Soderstrom J, Murray L, Little M, Daly FFS. Toxicology case of the month: carbamazepine overdose. Emergency Medical Journal 2006; 23: 869-871